Biosenta Inc

Chart & Performance

D1W1MN

P/E

—

P/S

7,950.69

EPS

—

Div Yield, %

0.00%

Shrs. gr., 5y

11.87%

Rev. gr., 5y

-2.24%

Revenues

-9.47%

Net income

-6m

L+324.13%

CFO

-551k

L+9.19%

Earnings

Feb 26, 2025

Profile

Biosenta Inc. develops, manufactures, and sells anti-microbial chemical compounds for household and industrial applications in Canada. It is involved in developing true, an anti-microbial, dual-action disinfectant that kills viruses, bacteria, mold, and germs on contact. The company also intends to manufacture and distribute Tri-Filler, an anti-microbial filler to perform filling and bulking functions. Biosenta Inc. was founded in 1986 and is based in Toronto, Canada.

URL

https://www.biosenta.com/

IPO date

Sep 22, 2005

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CAD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CAD in thousands, except ratios and share amounts	2023‑09	2022‑09	2021‑09	2020‑09	2019‑09	2018‑09	2017‑09	2016‑09	2015‑09
Income
Revenues	1 -9.47%	1 -99.32%
Cost of revenue	1,475	1,209
Unusual Expense (Income)
NOPBT	(1,474)	(1,208)
NOPBT Margin
Operating Taxes		27
Tax Rate
NOPAT	(1,474)	(1,235)
Net income	(6,300) 324.13%	(1,485) -27.62%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current	323	35
Long-term debt	5,295	60
Deferred revenue
Other long-term liabilities		(60)
Net debt	5,613	68
Cash flow
Cash from operating activities	(551)	(504)
CAPEX	(16)
Cash from investing activities	(16)
Cash from financing activities	545	420
FCF	(2,263)	(847)
Balance
Cash	6	27
Long term investments
Excess cash	6	27
Stockholders' equity	(7,856)	(1,910)
Invested Capital	5,619	(1,084)
ROIC		264.73%
ROCE	65.91%	40.37%
EV
Common stock shares outstanding	26,147	21,303
Price	0.42 5.00%	0.40 -24.53%
Market cap	10,982 28.87%	8,521 -9.66%
EV	16,595	8,589
EBITDA	(1,474)	(1,208)
EV/EBITDA
Interest	64	223
Interest/NOPBT